Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Spectinomycin dihydrochloride

SKU: orb1225650

Description

Spectinomycin Dihydrochloride is a new parenteral antibiotic prepared from Streptomyces spectabilis.

Research Area

Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number21736-83-4
MW405.27
Purity>98% (HPLC)
FormulaC14H26CL2N2O7
SMILESC[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O.Cl.Cl
Targetribosome
SolubilityWater: 81 mg/mL (199.86 mM); DMSO: 81 mg/mL warmed (199.86 mM)

Bioactivity

In Vivo
Spectinomycin dihydrochloride (20 mg/kg; i. m. ; 20-100 mg/kg; 9 d) shows the safety in healthy chicks. Spectinomycin dihydrochloride (10 mg/kg; i. v. ; single dose) has the major elimination pathway by renal excretion, approximately 55% is excreted into the urine in unchanged form. Pharmacokinetics of Spectinomycin dihydrochloride in Rat. Animal model: Arbor Acres plus broiler chicks (15-day-old). Dosage: 20 mg/kg, 60 mg/kg, 100 mg/kg. Administration: Intramuscular injection (chest muscles); 9 days. Result: Showed biosecurity of 20 mg/kg by complete blood count, biochemical parameters, histopathological, clinical signs, body weight gain, and feed conversion ratio (FCR). Resulted minor toxicity of 60 mg/kg.
In Vitro
Spectinomycin dihydrochloride selectively inhibits protein synthesis in cells and in extracts of Escherichia coli: Spectinomycin dihydrochloride (50 μg/mL) inhibits Escherichia coli growth rapidly and reversibly, and suppresses amino acid incorporation immediately. Spectinomycin dihydrochloride (1 μg/mL or 3 μM) inhibits polypeptide synthesis directed either by endogenous messenger RNA or by MS-2 bacteriophage RNA, with maximum inhibition of 70-80% in extracts of Escherichia coli. Spectinomycin dihydrochloride blocks the translocation of peptidyl-tRNAs from A-site to P-site by inhibiting the binding of elongation factor G to the ribosome. Spectinomycin dihydrochloride interacts specifically with the residues G1064 and 01192 in 16S rRNA and potentially makes it inactive. Spectinomycin dihydrochloride exhibits splicing inhibition and dependent on pH changes and Mg2+ concentration, indicating electrostatic interactions with the intron RNA.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Trospectomycin dihydrochloride [orb2695540]

    85951-37-7

    447.35

    C17H32Cl2N2O7

    50 mg, 100 mg, 25 mg
  • Spectinomycin dihydrochloride pentahydrate [orb1310291]

    99.96% (May vary between batches)

    22189-32-8

    495.35

    C14H24N2O7·2HCl·5H2O

    5 g, 1 g, 1 ml x 10 mM (in DMSO), 2 g, 500 mg
  • Spectinomycin dihydrochloride [orb1310292]

    >99.99% (May vary between batches)

    21736-83-4

    405.271

    C14H26Cl2N2O7

    2 g, 200 mg, 500 mg, 1 g, 10 g, 5 g
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Protocol Information

Available Sizes

Select a size below

500 mg
$ 90.00
1 g
$ 100.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry